Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8):
SEC Accession No. 0001193125-25-316216
Filing Date
2025-12-11
Accepted
2025-12-11 17:17:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B8 d19490d424b8.htm 424B8 276318
2 GRAPHIC g19490g03a37.jpg GRAPHIC 51709
  Complete submission text file 0001193125-25-316216.txt   340716
Mailing Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301
Business Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B8 | Act: 33 | File No.: 333-291002 | Film No.: 251565796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)